Plush city-centre offices are back in fashion
Unlock the Editor's Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
The rise of remote working is transforming office markets, but not in the way investors might have expected.
During the coronavirus pandemic, stark images of desolate city centres prompted warnings of a hollowing out, with traditional business districts empty while employees worked from home or from smaller local satellite offices. Five years on, the opposite is happening in cities like London: demand for prime central offices is surging, while those on the outskirts — or even just the slightly off-centre — are struggling.
If companies are battling to lure staff into the office, it helps to make that office as convenient and attractive as possible — hence Great Portland Estates, for example, keeping more than 90 per cent of its portfolio within walking distance of London's Elizabeth line.
The most high-profile illustration of the trend has been the stream of recent headlines about major companies abandoning Canary Wharf for the City of London. But it is not just a British phenomenon. Blackstone, the private equity group that owns €120bn worth of European real estate, says there are similar patterns across the continent.
On average, rents in European central business districts have grown at more than twice the pace of non-CBDs over the past five years, according to Savills. In Milan, vacancy rates in the central business district were just 2.4 per cent in the first quarter, according to CBRE, compared with 11 per cent for the rest of the city.
In Finland, Blackstone-owned Sponda reports a growing number of companies looking to relocate from the outskirts of Helsinki to the centre, a phenomenon that has helped drive prime rents up 14 per cent over the past year.
Other investors are taking notice. The few commercial property deals that are getting done in the high interest rate environment are focused on major city centres. There were €26bn worth of office sales, financing or recapitalisations in European central business districts in the 12 months to March, according to MSCI data, up 25 per cent year on year. Outside of central business districts, in contrast, volumes fell 10 per cent to €20bn.
Given the lack of new construction and the preponderance of long-term holders in many historic cities, the supply of quality buildings is likely to remain limited. That suggests rents can keep rising, and strengthens the argument that many listed property groups are undervalued.
GPE trades at a 30 per cent discount to its book value despite focusing on precisely the sorts of buildings that are seeing the highest demand. Many of its peers around the UK and mainland Europe are trading at similar levels, like Derwent and Helical in the UK, or Covivio in France and Inmobiliaria Colonial in Spain.
As workers go hybrid, so should investors — by sticking to those office properties that are best suited to a city-centre revival. An all-in bet on office real estate would be a high-risk move, because not all property companies are going to rebound. But that doesn't mean the whole industry needs a refurb.
nicholas.megaw@ft.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Posts falsely claim low-cost carriers to introduce standing seats in 2026
"Standing seats in planes: A new reality of budget airlines beginning 2026," reads a Malay-language Facebook post on May 18, 2025. It describes the seats as "a cross between bicycle seats and a standing position" and claims they are being introduced to reduce cost and increase capacity. The post features three images of the vertical, saddle-like seats designed to allow passengers to sit in a semi-upright position. The false claims spread after British tabloid Daily Mail published an article titled "Is this the future of travel? Low cost airlines could launch standing only seats as early as next year" on May 21, 2025 (archived link). The report claims that the SkyRider standing chairs, made by aircraft seat manufacturer Aviointeriors, can increase passenger capacity by 20 percent. Similar posts were shared elsewhere on Facebook. But Aviointeriors clarified in an Instagram post on May 23 that the "standing seats" were merely prototypes dating back to 2012 (archived link). "Designed as a bold response to one of the aviation industry's most pressing challenges, while maximizing space and ergonomics it was never meant to be taken at face value," the company said. A check on Aviointeriors' website also shows the SkyRider standing seats are not part of the company's catalogue (archived link). When contacted by AFP, the EASA confirmed that it had not received applications to certify standing seats in commercial aircraft. "Such seats would pose significant technical challenges, particularly in terms of emergency evacuation," it told AFP, adding that the design of a plane's fuselage does not allow for passengers to stand near windows. "Any airline wishing to introduce this type of seat will face significant challenges, both in terms of aircraft reconfiguration and in demonstrating compliance with strict safety and evacuation requirements." Irish low-cost carrier Ryanair also told AFP that the airline was not considering introducing the seats. However, its head Michael O'Leary said in 2009 that he would not have any problem introducing standing seats on planes, but pointed out that such a move will likely be rejected by the European Union for safety reasons.
Yahoo
30 minutes ago
- Yahoo
Global Market's Top 3 Stocks That Could Be Undervalued In June 2025
As global markets navigate a mixed economic landscape, with U.S. stocks climbing for the second consecutive week and European indices buoyed by easing monetary policies, investors are keenly observing the potential impacts of trade tensions and labor market shifts. Amid these developments, identifying undervalued stocks can be particularly appealing as they may offer opportunities for growth when market conditions are uncertain. Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$30.70 HK$61.36 50% Sparebank 68° Nord (OB:SB68) NOK179.38 NOK357.46 49.8% Sahara International Petrochemical (SASE:2310) SAR18.98 SAR37.71 49.7% PixArt Imaging (TPEX:3227) NT$220.00 NT$436.00 49.5% Montana Aerospace (SWX:AERO) CHF19.50 CHF38.68 49.6% Good Will Instrument (TWSE:2423) NT$44.30 NT$87.18 49.2% Exsitec Holding (OM:EXS) SEK128.50 SEK254.56 49.5% doValue (BIT:DOV) €2.258 €4.45 49.3% Airbus (ENXTPA:AIR) €163.92 €325.62 49.7% ABO Energy GmbH KGaA (XTRA:AB9) €36.70 €72.88 49.6% Click here to see the full list of 495 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Overview: SILICON2 Co., Ltd. is involved in the global distribution of cosmetics products and has a market cap of ₩3.40 billion. Operations: The company generates revenue primarily through its wholesale miscellaneous segment, which amounts to ₩787.27 million. Estimated Discount To Fair Value: 41.1% SILICON2 is trading at ₩61,800, significantly below its estimated fair value of ₩104,926.19, suggesting it may be undervalued based on cash flows. Despite high volatility in recent months, the company reported strong earnings growth of 134.2% over the past year and forecasts revenue and earnings growth above 20% annually. Recent results showed net income rising to KRW 38,785 million from KRW 25,535.55 million a year ago with improved earnings per share figures. The analysis detailed in our SILICON2 growth report hints at robust future financial performance. Click here and access our complete balance sheet health report to understand the dynamics of SILICON2. Overview: Qingdao Baheal Medical INC. is involved in the research, development, production, and sale of pharmaceutical products with a market cap of approximately CN¥11.10 billion. Operations: The company's revenue is derived from its activities in research, development, production, and sale of pharmaceutical products. Estimated Discount To Fair Value: 15.2% Qingdao Baheal Medical is trading at CNY 23.29, below its estimated fair value of CNY 27.46, indicating potential undervaluation based on cash flows. Despite a slight decline in recent sales and net income compared to the previous year, earnings are projected to grow significantly over the next three years. The company recently affirmed a dividend distribution plan for 2024, reflecting stable shareholder returns amidst moderate revenue growth expectations above the Chinese market average. Our growth report here indicates Qingdao Baheal Medical may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Qingdao Baheal Medical's balance sheet health report. Overview: Fositek Corp. operates in the manufacture and wholesale of electronic materials and components, with a market cap of NT$47.58 billion. Operations: The company's revenue primarily comes from its Electronic Components & Parts segment, generating NT$8.73 billion. Estimated Discount To Fair Value: 47% Fositek is trading at NT$762, significantly below its estimated fair value of NT$1,437.14, highlighting potential undervaluation based on cash flows. The company reported strong first-quarter earnings with net income rising to TWD 356.5 million from TWD 223.95 million year-over-year. Earnings are projected to grow substantially at 33.9% annually over the next three years, outpacing Taiwan's market average growth rates despite recent share price volatility and changes in company bylaws. The growth report we've compiled suggests that Fositek's future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of Fositek. Investigate our full lineup of 495 Undervalued Global Stocks Based On Cash Flows right here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A257720 SZSE:301015 and TWSE:6805. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Axios
an hour ago
- Axios
U.S. races to break China's hold on rare earth magnets
While U.S. trade negotiators work to ease an immediate shortage of rare earth magnets from China, the Trump administration is scrambling to line up viable alternatives that would reduce America's reliance on its chief economic rival. Why it matters: Small-but-powerful rare earth magnets are essential to high-tech products, from cars and robots to electronics and weapons. But China controls 90% of the world's supply of the critical components. The contentious trade relationship between the U.S. and China has amplified the economic and security risks of that reliance. Global automakers are "in full panic" that China's limits on rare earth exports will trigger supply chain shocks like the pandemic-related semiconductor shortages that occurred in 2021 and 2022. The big picture: It's not a new problem. U.S. officials have been talking about the need to mitigate American dependence on China for years. China also dominates processing of metals like lithium, cobalt, nickel and graphite used in batteries. The latest: U.S. and Chinese officials met Monday and Tuesday in London to try to iron out their trade issues, amid reports that China was willing to expedite export licenses for U.S. and European automakers if the U.S. loosened export controls on jet engine parts and software. Late Tuesday both sides said they'd reached a framework of a deal, pending approval from both countries' leaders, that would in theory resolve the most recent export issues. Yes, but: There's still an urgency to find alternative sources. President Trump in April called for an investigation into national security risks posed by U.S. reliance on imported processed critical minerals, including rare earth elements. He has also used a series of executive orders to try to bolster domestic supply chains, like fast-tracking environmental reviews for U.S. mining projects. In Congress, meanwhile, rare earth competition with China has galvanized both parties. A spate of bills would create a tax credit for production of high-performance rare earth magnets, use Defense Production Act authority to direct emergency funding, and establish an Energy Department program to finance minerals projects. Two Republicans and two Democrats are pressing legislation that allows the president to strike free trade agreements exclusively focused on critical minerals and rare earth elements. "There is fairly broad bipartisan support around becoming more resilient, especially in areas that invoke national security — and this is clearly one of them," Sen. Todd Young, an Indiana Republican leading that bill, told Axios last month. Zoom in: One deal that's getting a lot of attention is a potential partnership between California-based MP Materials and Saudi Arabia's flagship mining company, Maaden. The deal was inked in May on the sidelines of the U.S.-Saudi Investment Forum, coinciding with a broader agreement between the U.S. and Saudi Arabia to cooperate on energy and critical minerals. MP Materials operates California's Mountain Pass, the only rare-earths mine in the U.S., which produces 12% of the global supply. At maximum production, Mountain Pass could yield enough rare earths to supply more than 6 million electric vehicles, the company says. But the bottleneck is magnets, which MP Materials is just beginning to produce. Maaden, a fast-growing, government-controlled mining company, is developing mines for a variety of critical minerals, but doesn't produce rare earths today. What to watch: Together, the companies seek to jointly develop a vertically integrated rare earths supply chain in Saudi Arabia—mining, separation, refining and magnet production—for global consumption. Zoning and environmental regulations in the U.S. make it hard to open a rare earth mine, but Saudi Arabia moves more quickly and is anxious to wean its economy off of oil. Saudi expertise in petrochemical refining can be leveraged for minerals processing, while MP brings experience across the entire rare earths supply chain, including mining, refining and magnet production. Reality check: The preliminary deal is non-binding, so it could still fall apart.
